Yahoo! News: Weight Loss News |
- Vivus obesity drug has safety risks: FDA staff (Reuters)
- Obesity Linked to BPA Exposure (ContributorNetwork)
- EU agency says weight-loss drugs risk acceptable (Reuters)
- Medicare expenses growing faster for obese seniors: study (Reuters)
Vivus obesity drug has safety risks: FDA staff (Reuters) Posted: 17 Feb 2012 07:00 AM PST Reuters - Vivus Inc's obesity drug Qnexa helped people lose weight but may cause long-term health problems in overweight and obese patients, U.S. drugs reviewers said. |
Obesity Linked to BPA Exposure (ContributorNetwork) Posted: 16 Feb 2012 04:20 PM PST ContributorNetwork - COMMENTARY: Bisphenol-A, a synthetic estrogen, is wreaking havoc with the health of Americans in particular. China and Canada alike have deemed BPA a dangerous chemical, but the U.S. seems to be oblivious to the connection between its super-sized citizens and this chemical that has been linked to ailments such as obesity, heart disease and diabetes. |
EU agency says weight-loss drugs risk acceptable (Reuters) Posted: 16 Feb 2012 03:02 PM PST Reuters - The European Medicines Agency has decided that the benefits of orlistat-containing weight loss drugs, including GlaxoSmithKline's Alli and Roche's Xenical, outweigh the risk of very rare liver-related side effects. |
Medicare expenses growing faster for obese seniors: study (Reuters) Posted: 16 Feb 2012 09:49 AM PST Reuters - Medicare is spending more money every year per person, and each obese beneficiary tacks on an extra $149 a year to that increase, according to a new study. |
You are subscribed to email updates from Yahoo! News: Weight Loss News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
No comments:
Post a Comment